Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.05.03.442477

Predicting Environmental Chemical Carcinogenicity using a Hybrid Machine-Learning Approach

Abstract

Determining environmental chemical carcinogenicity is an urgent need as humans are increasingly exposed to these chemicals. In this study, we determined the carcinogenicity of wide variety real-life exposure chemicals in large scale. To determine chemical carcinogenicity, we have developed carcinogenicity prediction models based on the hybrid neural network (HNN) architecture. In the HNN model, we included new SMILES feature representation method, by modifying our previous 3D array representation of 1D SMILES simulated by the convolutional neural network (CNN). We used 653 molecular descriptors modeled by feed forward neural network (FFNN), and SMILES as chemical features to train the models. We have developed three types of machine learning models: binary classification models to predict chemical is a carcinogenic or non-carcinogenic, multiclass classification models to predict severity of the chemical carcinogenicity, and regression models to predict median toxic dose of the chemicals. Along with the hybrid neural network (HNN) model that we developed, Random Forest (RF), Bootstrap Aggregating (Bagging) and Adaptive Boosting (AdaBoost) methods were also used for binary and multiclass classification. Regression models were developed using HNN, RF, Support Vector Regressor (SVR), Gradient Boosting (GB), Kernel Ridge (KR), Decision Tree with AdaBoost (DT), KNeighbors (KN), and a consensus method. For binary classification, our HNN model predicted with an average accuracy of 74.33% and an average AUC of 0.806, for multiclass classification, the HNN model predicted with an average accuracy of 50.58% and an average micro-AUC of 0.68, and for regression model, the consensus method achieved R2 of 0.40. The predictive performance of our models based on a highly diverse chemicals is comparable to the literature reported models that included the similar and less diverse molecules. Our models can be used in identifying the potentially carcinogenic chemicals for a wide variety of chemical classes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Limbu, S., Dakshanamurthy, S.. 2021-05-04. Predicting Environmental Chemical Carcinogenicity using a Hybrid Machine-Learning Approach. https://doi.org/10.1101/2021.05.03.442477

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration

Antisense oligonucleotides (ASOs) are a powerful therapeutic modality, but their full potential is hindered by pharmacokinetic properties that affect tissue and cellular delivery. Lipid conjugation is increasingly used to modulate ASO's biodistribution and promote extrahepatic activity, yet lipid dependent effects on in vivo functional delivery, particularly in the central nervous system (CNS), remain less explored. Here, we performed a side by side in vivo comparison of cholesterol, palmitic acid (C16:0), docosanoic acid (C22:0), and eicosapentaenoic acid (C20:5) conjugated to a fully phosphorothioated 3 10 3 LNA gapmer ASO targeting the Malat1 long non coding RNA. Lipid-ASO conjugates were administered systemically or locally in the brain of mice and evaluated for tissue level and cellular level distribution by imaging, qPCR and single-cell RNA sequencing, simultaneously annotating cell origin and global transcriptional changes within the cell. Following systemic administration in mice, lipid conjugation improved overall multi organ efficacy compared to unconjugated ASO, but with pronounced tissue specific differences. Single cell sequencing of liver and heart transcriptomes revealed lipid dependent cellular uptake patterns and transcriptional responses distinct from administration of unconjugated ASO. After intracerebroventricular administration, selected fatty acid conjugates enhanced silencing in deep brain regions such as the striatum, whereas cholesterol conjugation impaired functional delivery despite increased CNS retention. Light-sheet microscopy showed restricted parenchymal penetration of cholesterol ASOs compared with broader but heterogeneous distribution of palmitic acid conjugate. Together, these findings demonstrate that lipid identity critically determines ASO efficacy, productive cellular uptake, and regional CNS engagement, emphasizing the need for context specific lipid design in ASO therapeutic development.

pharmacology and toxicology↗

Novel Dissymmetric Ionizable Lipid-Assembled Lipid Nanoparticles for Delivery of Ferroptosis-Related siRNA in Diabetic Treatment

Small interfering RNA (siRNA) enables precise post-transcriptional gene silencing for refractory diseases, yet its clinical translation remains limited by the lack of safe and efficient delivery vectors. Inspired by the dissymmetric alkyl chain architecture of natural membrane phospholipids, we designed and synthesized 34 novel ionizable lipids with dissymmetric hydrophobic tails and formulated them into lipid nanoparticles (LNPs). Through systematic physicochemical and biological assessments, we established clear structure-activity relationships and identified two lead LNPs (O14-LNP, H18a-LNP) with superior endosomal escape capacity, enhanced in vivo gene silencing potency, and favorable biosafety relative to the clinical benchmark MC3-LNP. In both streptozotocin-induced and spontaneous db/db type 2 diabetes (T2D) mouse models, lead LNPs delivering ferroptosis-related siRNAs effectively ameliorated glucose and lipid metabolic disorders, restored islet function, and alleviated hepatic steatosis. This study not only lays a theoretical foundation for the rational design of novel ionizable lipids, but also validates the therapeutic potential of siRNA therapy targeting ferroptosis, providing a versatile delivery platform and targeted therapeutic strategy for the treatment of T2D.

pharmacology and toxicology↗

Discovery and synthesis of hydroxy-L-proline based blockers of the neutral amino acid transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2).

The conformationally restricted heterocycle hydroxy-L-proline is a versatile scaffold for the synthesis of diverse multi-functionalized pyrrolidines for probing the ligand binding sites of biological targets. With the goal to develop new inhibitors of the widely expressed amino acid transporters SLC1A4 and SLC1A5 (also known as ASCT1 and ASCT2), we synthesized and functionally screened a series of hydroxy-L-proline derivatives or prolinols using electrophysiological and radio-labeled uptake assays on amino acid transporters from the SLC1, SLC7, and SLC38 solute carrier families. We identified a number of synthetic prolinols that act as selective high-affinity inhibitors of the SLC1 functional subfamily comprising the neutral amino acid transporters SLC1A4 and SLC1A5. The active and inactive prolinols were computationally docked into a threaded homology model and analyzed with respect to predicted molecular orientation and observed pharmacological activity. The series of hydroxy-L-proline derivatives identified here represents a new class of potential agents to pharmacologically modulate SLC1A4 and SLC1A5, amino acid exchangers that play important roles in a wide range of physiological and pathophysiological processes.

pharmacology and toxicology↗